# Topiramate in the Treatment of Pathological Gambling

> **NCT00245583** · PHASE3 · TERMINATED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 42 (actual)

## Conditions studied

- Pathological Gambling

## Interventions

- **DRUG:** Topiramate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00245583
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-10
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 42 (ACTUAL)
- **Why stopped:** low enrollment
- **Last updated:** 2019-07-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00245583

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00245583, "Topiramate in the Treatment of Pathological Gambling". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00245583. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*